Product Images Xeloda
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Xeloda NDC 61269-470 by H2-pharma, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - xeloda 01
Figure 1 - xeloda 02
This is data from a clinical trial comparing the efficacy of two chemotherapeutic drugs, 5-FU+ LEUCOVORIN and CAPECITABINE. The data shows the number of patients in each treatment group at different time points, expressed in months since randomization. The percentage of patients still at risk (i.e. alive or disease-free) at each time point is also provided.*
Figure 2 - xeloda 03
This appears to be a graph showing survival rates for two different treatment groups over a period of 96 months since randomization. The two treatments are 5-FU+ LEUCOVORIN and CAPECITABINE and their respective survival rates are shown in the graph.*
Figure 3 - xeloda 04
This is a chart with estimated probability percentages for two different chemotherapy treatments over a certain period of time. The treatments mentioned are 5-FU + Leucovorin (Mayo Regimen) and Xeloda 1250 taken twice daily intermittently. The chart shows the estimated probability of success rates for each treatment over time. The horizontal axis represents the number of days, and the vertical axis represents the percentage of success rate.*
Figure 4 - xeloda 05
This appears to be a chart showing the estimated probability for a treatment involving "Docetaxel" administered at varying doses and frequencies over a period of three weeks. The chart displays a probability scale ranging from 0 to 1 and shows the estimated probability for the treatment at each dose and frequency combination over a 800 day period. The text does not provide any further context or information.*
Figure 5 - xeloda 06
PRINCIPAL DISPLAY PANEL - 150 mg Tablet Bottle Carton - xeloda 07
This is a description of Xeloda, a medication with NDC 61269-470-60. It is in tablet form, with each containing 150 mg of capecitabine. There are 60 tablets in each package provided by CHEPLAPHARM. The text also includes a warning that Xeloda is a hazardous drug.*
PRINCIPAL DISPLAY PANEL - 500 mg Tablet Bottle Carton - xeloda 08
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.